Search

everythinglearnresearchcommunity

for

Search:↓

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Apremilast did not work for treating severe alopecia areata.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

A patient with complete hair loss regrew all her hair using tofacitinib.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Some horses lose hair without inflammation or itching due to various conditions, and while mainly a cosmetic issue, diagnosis requires examination and biopsies, and breeding is not advised if it's hereditary.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

CD2 might be a new treatment target for patchy alopecia areata.

The study suggests silicon might be important for healthy hair, as less silicon was found in people with hair loss.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.

A child's hair loss from alopecia areata was fully reversed in five months using diet and supplements.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Alopecia areata is an autoimmune disorder causing hair loss and can impact mental health.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Balancing testosterone may reduce COVID-19 severity.

Imiquimod shows promise as a non-invasive treatment for certain HPV-related lesions, but more research is needed to optimize its use.

Nanotechnology shows promise in improving hair loss treatments by enhancing drug delivery and reducing side effects.